PMS-CINACALCET: Affected lots may exceed the established acceptable intake limit for N-nitroso-cinacalcet.
Brand(s)
Last updated
Summary
Product
PMS-CINACALCET Tablets (30MG, 60 MG, 90 MG)
Issue
Health products - Product safety
What to do
Consult your health care professional if you have any health concerns.
Distribution
National
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| PHARMASCIENCE INC | PMS-CINACALCET | DIN 02517604 | Tablet | CINACALCET (CINACALCET HYDROCHLORIDE) 30 MG | T2304707 |
| PHARMASCIENCE INC | PMS-CINACALCET | DIN 02517612 | Tablet | CINACALCET (CINACALCET HYDROCHLORIDE) 60 MG | T2304708 |
| PHARMASCIENCE INC | PMS-CINACALCET | DIN 02517620 | Tablet | CINACALCET (CINACALCET HYDROCHLORIDE) 90 MG | T2304718 |
Issue
The affected lots may exceed the established acceptable intake limit for N-nitroso-cinacalcet.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
PHARMASCIENCE INC
100 6111 Royalmount Ave
Montreal
QUÉBEC
CANADA H4P 2T4
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type I
Identification number
RA-76775
Get notified
Receive notifications for new and updated recalls and alerts by category.